• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    More On TNGN

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Tengion, Inc. (TNGN)

    -Other OTC
    0.00 Down 0.01(70.30%) Dec 30
    Add to Portfolio
    Prev Close:0.01
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:7.50
    Beta:1.87
    Earnings Date:Mar 24 - Mar 30 (Est.)
    Day's Range:N/A - N/A
    52wk Range:0.01 - 0.35
    Volume:0
    Avg Vol (3m):385,834
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-3.89
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    ยป More Headlines for TNGN

    Comparison

    Symbol% ChgMkt Cap
    TNGNDown 70.30%N/A
    IARTDown 1.75%1.97B
    OSIRUp 0.81%601.29M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Tengion, Inc. operates as a regenerative medicine company. The company focuses on discovering, developing, manufacturing, and commercializing a range of neo-organs or products composed of living cells with or without synthetic or natural materials... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback